Peter F.A. Mulders - Concepedia

Author

Peter F.A. Mulders

Also Known As

P F A Mulders, P F Mulders, P Mulders, P. F. A. MULDERS, P. F. A. Mulders, P. F.A. Mulders, P. Mulders, P.F. Mulders, P.F.A. Mulders, PETER F.A. MULDERS

399

Publications

27.4K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Université de Montréal Centre Hospitalier Universitaire de Rennes Centre Hospitalier Universitaire de Saint-Étienne

About

Peter F.A. Mulders is an author at Radboud University Nijmegen specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	56	7.1K
2	Health Sciences	5	5	548
3	Engineering	3	3	53
4	Public Health	1	1	12
5	Allergy	1	1	14

Peter F.A. Mulders

119

Publications

20.5K

Citations

H-Index

Page 1

	Year	Citations
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim Fizazi, Fred Saad, New England Journal of Medicine	2012	4.5K
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, New England Journal of Medicine	2012	2.8K
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update Börje Ljungberg, Nigel C. Cowan, Damian Hanbury, European Urology UrologyGenitourinary CancerMedicineEau GuidelinesOncology	2010	1.3K
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience Jean‐Jacques Patard, Emmanuelle Leray, Nathalie Rioux‐Leclercq, Journal of Clinical Oncology	2005	750
Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram Pierre I. Karakiewicz, Alberto Briganti, Felix K.‐H. Chun, Journal of Clinical Oncology	2007	555
Renal Cell Carcinoma Guideline Börje Ljungberg, Damian Hanbury, M. Kuczyk, European Urology UrologyGenitourinary CancerRenal PathologyMedicineNephrology	2007	538
SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE Oleg Shvarts, J. Lam, Vincenzo Ficarra, The Journal of Urology	2004	526
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib Axel Bex, Peter F.A. Mulders, Michael A.S. Jewett, JAMA Oncology	2018	468
1653: Safety and Efficacy of Partial Nephrectomy for all T1 Tumors Based on an International Multicenter Experience Jean‐Jacques Patard, Oleg Shvarts, Allan J. Pantuck, The Journal of Urology Surgical OncologyRenal PathologyT1 TumorsSurgeryReconstructive Urology	2004	468
Guidelines on Renal Cell Carcinoma Börje Ljungberg, Damian Hanbury, M. Kuczyk, UrologyRenal FunctionHealth SciencesGenitourinary CancerKidney Research	2007	423

Page 1